Thursday, January 28, 2021

CytoDyn Inc.’s Vyrologix (leronlimab-Vyrologix) shows impressive results in critically ill COVID-19 patients



Wazzup Pilipinas!

CytoDyn Inc., a late-stage biotechnology company developing CCR5 inhibiting drug leronlimab- Vyrologix, showed impressive results in improving the immune function of critically ill COVID-19 patients in the United States.

Leronlimab- Vyrologix is a humanized monoclonal antibody drug used to treat HIV patients. The drug is a C-C chemokine receptor type 5 (CCR5) antagonist that protects healthy T cells from viral infection. The CCR5 receptor plays a crucial role in modulating immune cell trafficking to sites of inflammation.[1] Because of the drug’s ability to mitigate the cytokine storm which is common in COVID-19 fatalities,[2] it has become the basis for its study as a potential COVID-19 treatment.[3]

Leronlimab- Vyrologix appears to be a powerful treatment with hardly any drug related serious adverse events. CytoDyn’s recent treatment of patients under eIND (Emergency Investigational New Drug) with leronlimab for COVID-19 infection have shown impressive results as the drug reduced the plasma viral load and restored the immune function by day 7.5, [4]

CytoDyn has already completed its Phase 2 clinical trial for COVID-19, a double-blinded, randomized clinical trial for mild-to-moderate COVID-19 patients in the U.S. The company has also recently announced that they have completed the enrollment of 394 patients in its Phase 2b/3 randomized clinical trial for the severe-to-critically ill COVID-19 population.

Cytodyn has appointed Chiral Pharma, a subsidiary of New Marketlink Pharmaceutical Corporation (NMPC) as its authorized partner for the distribution of Leronlimab-Vyrologix to the Philippines subject to registration approval of Philippine Food and Drug Administration. Through the partnership, the companies are working to register Leronlimab under a licensed physician’s request for Compassionate Special Permit (CSP). It is the desire of Cytodyn and Chiral Pharma to make Leronlimab immediately available to patients with Covid-19.


[1] https://ghr.nlm.nih.gov/gene/CCR5


[2] https://www.webmd.com/lung/news/20200417/cytokine-storms-may-be-fueling-some-covid-deaths


[3] https://www.cytodyn.com/newsroom/press-releases/detail/399/leronlimab-used-in-seven-patients-with-severe-covid-19


[4] https://www.cytodyn.com/newsroom/press-releases/detail/452/impressive-results-from-cytodyns-phase-2-covid-19-trial





4 comments:

  1. Buy reviews on Reddit 24/7 from a successful team of Reddit hacks https://reddit-marketing.pro that will cover all facets of Reddit marketing and make your content go viral. We have over 5 years of experience with Reddit hacks and many successful cases. Since January 2019, they have raised over $32 million in tokens.

    ReplyDelete
  2. This comment has been removed by the author.

    ReplyDelete
  3. This comment has been removed by the author.

    ReplyDelete
  4. Hi there, are you familiar with the subject of casinos, I hope I do not have to explain how it all works, well, the slots are programmed machines which in a certain sequence give out the right numbers and there is always a certain percentage of payout, but there is one great https://mrcasinos.net/bonusi-casino/ casino percentage of winnings over 95, so the best slots here

    ReplyDelete